Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Song

Showing results (1211-1220 of 1,224) with videos related to

Pageof 123
Sort By:
Cell Reports|December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastomaChristopher S Hackett, David A Quigley, Robyn A Wong, et al.
Oncotarget|October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaDominik Bogen, Jun S Wei, David O Azorsa, et al.
Blood Advances|January 6, 2023
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemiaKatherine E Masih, Rebecca A Gardner, Hsien-Chao Chou, et al.
Journal of the American College of Cardiology|June 11, 2016
Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC RegistryJonathan W Weinsaft, Richard B Devereux, Liliana R Preiss, et al.
The Journal of Nutrition, Health & Aging|January 31, 2018
Peripheral Blood Leukocyte Telomere Length Is Associated with Age but Not Renal Function: A Cross-Sectional Follow-Up StudyW-G Zhang, L-P Jia, J Ma, et al.
BMJ Open|August 29, 2019
Early Life Exposure in Mexico to ENvironmental Toxicants (ELEMENT) ProjectWei Perng, Marcela Tamayo-Ortiz, Lu Tang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2021
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F Shern, Joanna Selfe, Elisa Izquierdo, et al.
Cell Reports. Medicine|September 29, 2023
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.
Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.
Science Translational Medicine|December 4, 2015
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarkerWenjun Ju, Viji Nair, Shahaan Smith, et al.
Pageof 123

Showing results (1211-1220 of 1,224) with videos related to

Sort By:
Pageof 123
Cell Reports|December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastomaChristopher S Hackett, David A Quigley, Robyn A Wong, et al.
Oncotarget|October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaDominik Bogen, Jun S Wei, David O Azorsa, et al.
Blood Advances|January 6, 2023
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemiaKatherine E Masih, Rebecca A Gardner, Hsien-Chao Chou, et al.
Journal of the American College of Cardiology|June 11, 2016
Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC RegistryJonathan W Weinsaft, Richard B Devereux, Liliana R Preiss, et al.
The Journal of Nutrition, Health & Aging|January 31, 2018
Peripheral Blood Leukocyte Telomere Length Is Associated with Age but Not Renal Function: A Cross-Sectional Follow-Up StudyW-G Zhang, L-P Jia, J Ma, et al.
BMJ Open|August 29, 2019
Early Life Exposure in Mexico to ENvironmental Toxicants (ELEMENT) ProjectWei Perng, Marcela Tamayo-Ortiz, Lu Tang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2021
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F Shern, Joanna Selfe, Elisa Izquierdo, et al.
Cell Reports. Medicine|September 29, 2023
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.
Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.
Science Translational Medicine|December 4, 2015
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarkerWenjun Ju, Viji Nair, Shahaan Smith, et al.
Pageof 123